Balyasny Asset Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,533
| Closed | -$153K | – | 2053 |
|
|
2024
Q4 | $153K | Buy |
42,533
+22,789
| +115% | +$82K | ﹤0.01% | 1775 |
|
|
2024
Q3 | $113K | Sell |
19,744
-1,916,395
| -99% | -$10.9M | ﹤0.01% | 1851 |
|
|
2024
Q2 | $8.94M | Sell |
1,936,139
-499,241
| -20% | -$2.31M | 0.02% | 669 |
|
|
2024
Q1 | $19.9M | Buy |
2,435,380
+731,111
| +43% | +$5.97M | 0.03% | 468 |
|
|
2023
Q4 | $9.63M | Buy |
+1,704,269
| New | +$9.63M | 0.02% | 642 |
|
|
2023
Q3 | – | Sell |
-11,686
| Closed | -$32.1K | – | 1803 |
|
|
2023
Q2 | $32.1K | Buy |
+11,686
| New | +$32.1K | ﹤0.01% | 1744 |
|